Treatment with ginseng total saponins reduces the secondary brain injury in rat after cortical impact

Journal of Neuroscience Research

Volumn 90, Issue 7, 2012, Pages 1424-1436

  Xia, Lei ^a,b   Jiang, Zheng Lin ^a   Wang, Guo Hua ^a   Hu, Bao Yin ^a   Ke, Kai Fu ^a  

^a NANTONG UNIVERSITY   (China)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Ginseng total saponins; Inflammatory response; Neuronal apoptosis; Nitrative stress; Oxidative stress; Traumatic brain injury

Indexed keywords

CASPASE 3; GINSENG SAPONIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN EDEMA; CELL LOSS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NICK END LABELING; NISSL STAINING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY; UPREGULATION; WATER CONTENT;

ANIMALS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL CORTEX; MALE; OXIDATIVE STRESS; PANAX; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE NITROGEN SPECIES; SAPONINS;

EID: 84862818879     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22811     Document Type: Article

References (57)

1. Adamides AA, Winter CD, Lewis PM, Cooper DJ, Kossmann T, Rosenfeld JV. 2006. Current controversies in the management of patients with severe traumatic brain injury. ANZ J Surg 76: 163-174.
2. Attele AS, Wu JA, Yuan CS. 1999. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
3. Bayir H, Kochanek PM, Clark RS. 2003. Traumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit. Crit Care Clin 19: 529-549.
4. Beaumont A, Marmarou A, Hayasaki K, Barzo P, Fatouros P, Corwin F, Marmarou C, Dunbar J. 2000. The permissive nature of blood-brain barrier (BBB) opening in edema formation following traumatic brain injury. Acta Neurochir Suppl 76: 125-129.
5. Chen LM, Zhou XM, Cao YL, Hu WX. 2008. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Products Res 10: 439-445.
6. Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH. 2003. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol 473: 1-7.
7. Chen XC, Zhou YC, Chen Y, Zhu YG, Fang F, Chen LM. 2005. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin 26: 56-62.
8. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 550: 173-179.
9. Choi K, Kim M, Ryu J, Choi C. 2007. Ginsenosides compound K and Rh-2 inhibit tumor necrosis factor-α-induced activation of the NF-κB and JNK pathways in human astroglial cells. Neurosci Lett 421: 37-41.
10. Combs DJ, D'Alecy LG. 1987. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1, 3-butanediol. Stroke 18: 503-511.
11. DeGraba TJ, Ostrow P, Hanson S, Grotta JC. 1994. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia. J Cereb Blood Flow Metab 14: 262-268.
12. Dempsey RJ, Baskaya MK, Dogan A. 2000. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 47: 399-404.
13. Donkin JJ, Vink R. 2010. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments. Curr Opin Neurol 23: 293-299.
14. Doyle KP, Simon RP, Stenzel-Poore MP. 2008. Neuropharmacology-special issue on cerebral ischemia mechanisms of ischemic brain damage. Neuropharmacology 55: 310-318.
15. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. 1981. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211: 67-77.
16. Flanagan SR, Cantor JB, Ashman TA. 2008. Traumatic brain injury: future assessment tools and treatment prospects. Neuropsychiatr Dis Treat 4: 877-892.
17. Greve MW, Zink BJ. 2009. Pathophysiology of traumatic brain injury. Mt Sinai J Med 76: 97-104.
18. Hwang YP, Jeong HG. 2010. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol 242: 18-28.
19. Ishige N, Pitts LH, Berry I, Carlson SG, Nishimura MC, Moseley ME, Weinstein PR. 1987. The effect of hypoxia on traumatic head injury in rats: alterations in neurologic function, brain edema, and cerebral blood flow. J Cereb Blood Flow Metab 7: 759-767.
20. Ji YC, Kim YB, Park SW, Hwang SN, Min BK, Hong HJ, Kwon JT, Suk JS. 2005. Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury. J Korean Med Sci 20: 291-296.
21. Jiang S, Jiang ZL. 2003. Protective effect of ginsenoside Rb1 on ischemic brain injury in rat. J Apoplexy Nerv Dis 20: 415-417.
22. Jiang ZL, Wu XM, Jin SY, Chen YP, Zhuang J. 2000. Effect of ginsenosides on hypoxic brain injury in hippocampal slice. Chin J Naut Med 7: 28-32.
23. Jiang ZL, Chen YR, Zhou C, Shi JS, Duan SM. 2001. Glutamate-related mechanisms of ginsenosides against hypoxic-ischemic brain damage. Chin J Appl Physiol 17: 105-108.
24. Joo SS, Won TJ, Lee YJ, Hwang KW, Lee SG, Yoo YM, Lee DI. 2006. Ginsenoside Rg3 from red ginseng prevents damage of neuronal cells through the phosphorylation of the cell survival protein Akt. Food Sci Biotechnol 15: 244-247.
25. Kiefer D, Pantuso T. 2003. Panax ginseng. Am Fam Physician 68: 1539-1542.
26. Kim KR, Chung TY, Shin H, Son SH, Park KK, Choi JH, Chung WY. 2010. Red ginseng saponin extract attenuates murine collagen-induced arthritis by reducing pro-inflammatory responses and matrix metalloproteinase-3 expression. Biol Pharm Bull 33: 604-610.
27. Kim ND, Pokharel YR, Kang KW. 2007. Ginsenoside Rd enhances glutathione levels in H4IIE cells via NF-κB-dependent γ-glutamylcysteine ligase induction. Pharmazie 62: 933-936.
28. Li N, Liu B, Dluzen DE, Jin Y. 2007. Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol 111: 458-463.
29. Li XY, Liang J, Tang YB, Zhou JG, Guan YY. 2010. Ginsenoside Rd prevents glutamate-induced apoptosis in rat cortical neurons. Clin Exp Pharm Physiol 37: 199-204.
30. Liao B, Newmark H, Zhou R. 2002. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp Neurol 173: 224-234.
31. Lim JH, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, Aburaya J, Ishihara K, Sakanaka M. 1997. Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root. Neurosci Res 28: 191-200.
32. Lin WM, Zhang YM, Moldzio R, Rausch WD. 2007. Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. J Neural Transm 72( Suppl): 105-112.
33. López MVN, Cuadrado MPGS, Ruiz-Poveda OMP, Del Fresno AMV, Accame MEC. 2007. Neuroprotective effect of individual ginsenosides on astrocytes primary culture. Biochim Biophys Acta 1770: 1308-1316.
34. Maas AIR, Stocchetti N, Bullock R. 2008. Moderate and severe traumatic brain injury in adults. Lancet Neurol 7: 728-741.
35. Marmarou A, Signoretti S, Aygok G, Fatouros P, Portella G. 2006. Traumatic brain edema in diffuse and focal injury: cellular or vasogenic? Acta Neurochir Suppl 96: 24-29.
36. Niizuma K, Endo H, Chan PH. 2009. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109( Suppl 1): 133-138.
37. Park EK, Choo MK, Han MJ, Kim DH. 2004. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immumn 133: 113-120.
38. Park J, Cho JY. 2009. Anti-inflammatory effects of ginsenosides from Panax ginseng and their structural analogs. Afr J Biotechnol 8: 3682-3690.
39. Park JK, Namgung U, Lee CJ, Park JO, Jin SH, Kwon OB, Ko SR, Kim SW, Kang EJ, Ko JH, Lee SM, Kim DH, Won MH. 2005. Calcium-independent CaMKII activity is involved in ginsenoside Rb1-mediated neuronal recovery after hypoxic damage. Life Sci 76: 1013-1025.
40. Park JS, Park EM, Kim DH, Jung K, Jung JS, Lee EJ, Hyun JW, Kang JL, Kim HS. 2009. Anti-inflammatory mechanism of ginseng saponins in activated microglia. J Neuroimmunol 209: 40-49.
41. Roberts I, Schierhout G, Alderson P. 1998. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J Neurol Neurosurg Psychiat 65: 729-733.
42. Robertson CL, Scafidi S, McKenna MC, Fiskum G. 2009. Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury. Exp Neurol 218: 371-380.
43. Rudakewich M, Ba F, Benishin CG. 2001. Neurotrophic and neuroprotective actions of ginsenosides Rb1 and Rg1. Planta Med 67: 533-537.
44. Samukawa K, Suzuki Y, Ohkubo N, Aoto M, Sakanaka M, Mitsuda N. 2008. Protective effect of ginsenosides Rg2 and Rh1 on oxidation-induced impairment of erythrocyte membrane properties. Biorheology 45: 689-700.
45. Shen L, Zhang J. 2003. Ginsenoside Rg1 increases ischemia-induced cell proliferation and survival in the dentate gyrus of adult gerbils. Neurosci Lett 344: 1-4.
46. Shohami E, Beit-Yannai E, Horowitz M, Kohen R. 1997. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 17: 1007-1019.
47. Soares HD, Hicks RR, Smith D, McIntosh TK. 1995. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15: 8223-8233.
48. Tu LH, Ma J, Liu HP, Wang RR, Luo J. 2009. The Neuroprotective effects of ginsenosides on calcineurin activity and tau phosphorylation in SY5Y cells. Cell Mol Neurobiol 29: 1257-1264.
49. Wu CF, Bi XL, Yang JY, Zhan JY, Dong YX, Wang JH, Wang JM, Zhang RW, Li M. 2007. Differential effects of ginsenosides on NO and TNF-α production by LPS-activated N9 microglia. Int Immunopharmacol 7: 313-320.
50. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ, Yuan CS. 2006. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 532: 201-207.
51. Yang XF, Liu WG, Shen H, Gong JB, Yu J, Hu WW, Lu ST, Zheng XJ, Fu WM. 2005. Correlation of cell apoptosis with brain edema and elevated intracranial pressure in traumatic brain injury. Chin J Traumatol 8: 96-100.
52. Ye RD, Han JL, Kong XW, Zhao LZ, Cao R, Rao ZR, Zhao G. 2008. Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol Pharm Bull 31: 1923-1927.
53. Ye RD, Li NL, Han JL, Kong XW, Cao R, Rao ZR, Zhao G. 2009. Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res 64: 306-310.
54. Yoo YI, Lee HS, Kim DH, Han MJ. 2009. Effect of red ginseng and its representative constituents, ginsenosides Rg3 and Rh2, on dextran sulfate sodium-induced colitis in mice. Food Sci Biotechnol 18: 262-266.
55. Zhang B, Matsuda S, Tanaka J, Tateishi N, Maeda N, Wen TC, Peng H, Sakanaka M. 1998. Ginsenoside Rb(1) prevents image navigation disability, cortical infarction, and thalamic degeneration in rats with focal cerebral ischemia. J Stroke Cerebrovasc Dis 7: 1-9.
56. 2+ channels. Eur J Pharmacol 586: 90-99.
57. Zhao HF, Li Q, Zhang ZF, Pei XR, Wang JB, Li Y. 2009. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res 1256: 111-122.